Biotech

Mesoblast Limited (ASX:MSB) Announce United States FDA Clears Phase 2 Trial For Congestive Heart Failure

🕔6/5/2008 11:30:58 AM

Australia's regenerative medicine company, Mesoblast Limited (ASX:MSB)(USOTC:MBLTY)(PINK:MEOBF), today announced that the United States Food and Drug Administration (US FDA) had cleared an Investigational New Drug (IND) submission by its US-based sister company, Angioblast Systems Inc., to commence a Phase 2 trial of the stem cell platform technology for treating patients with congestive heart failure.

Read Full Article▸

Benitec Limited (ASX:BLT) Delays Capital Raising Pending Restructure Of Relationship With CSIRO

🕔5/23/2008 5:40:02 PM

The Directors of Benitec Limited (ASX: BLT)(PINK: BNIKF) have decided to suspend the planned non-renounceable rights issue. The underwriter wants Benitec to restructure its relationship with CSIRO before proceeding with the raising of funds (as announced to the ASX on Friday 16 May 2008) as it believes this will add further value to Benitec.

Read Full Article▸

Helicon Group Limited (ASX:HCG) Present The Company Profile and The China Opportunity

🕔5/21/2008 10:04:30 AM

Helicon Group Limited (ASX: HCG) is a pharmaceutical and healthcare company with an innovative strategy, listed on the Australian Securities Exchange. Its business is to identify and exploit niche market opportunities in the specialty pharmaceutical and healthcare markets of China and North Asia and to participate in the significant growth that has been projected for those markets over the next 20 years.

Read Full Article▸

Benitec Limited (ASX:BLT) To Raise A$5.1M Through Proposed Underwritten Non-Renounceable Rights Issue

🕔5/16/2008 4:25:04 PM

The Directors of Benitec Limited (ASX: BLT)(PINK: BNIKF) today announced that the Company proposes to raise approx $5.1 million (before expenses to the offer) by undertaking a fully underwritten non-renounceable rights issue.

Read Full Article▸

Mesoblast Limited (ASX:MSB) Announce Near Term Commercialization of Three Bone And Cartilage Products

🕔5/13/2008 2:11:52 PM

Mesoblast Limited's (ASX: MSB)(PINK:MBLTY) record of accomplishment since its ASX listing in December 2004 has been first rate. Within only 3.5 years, the Company has established itself as a world leader in the development of innovative biological products in the emerging and potentially highly lucrative regenerative medicine field.

Read Full Article▸

Helicon Group Limited (ASX:HCG) Secures Exclusive China Rights For Collatamp G, An Innovative Drug Release Surgical Implant

🕔5/12/2008 2:48:44 PM

HELICON GROUP LIMITED (ASX: HCG) announced today that it had acquired the exclusive licensing rights from EUSA Pharma to Collatamp(R) G for the Chinese market.

Read Full Article▸

Starpharma Holdings Limited (ASX:SPL) Reports Positive VivaGel(R) Clinical Study Results

🕔5/12/2008 11:33:47 AM

Starpharma Holdings Limited (ASX:SPL, OTCQX:SPHRY) today announced positive results of a clinical trial that achieved all its objectives demonstrating that 3% SPL7013 Gel (VivaGel(R)) was safe and well-tolerated in sexually abstinent women when administered vaginally, twice daily for 14 days.

Read Full Article▸

Banking & Finance

Read More

Oil Gas & Energy

Read More

Life Sciences

Read More

Social Media

Latest Headlines